BioNTech founders Uğur Şahin and Özlem Türeci are embarking on a new venture, with their original investors and co-founders, Thomas and Andreas Strüngmann, expressing interest in investing again. This move follows their stepping back from BioNTech's leadership, highlighting their continued focus on scientific innovation and entrepreneurship.

Uğur Şahin és Özlem Türeci új mRNS-startupot alapítanak.